6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity

摘要

Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess improved PDE IV inhibition compared to theophylline or rolipram, with improved selectivity with regard to, e.g., PDE V inhibition. The present invention includes compounds of Formula I:wherein the substituents are as disclosed herein.